TFF3 and neoplasm: Pandey et al., in a study conducted to evaluate the role of tamoxifen in the EC, observed that elevated TFF3 protein expression was found in EC but not in normal endometrial tissue, and its elevated expression in EC cells increased oncogenicity, invasiveness and tumor growth, as well as myometrial invasion.